| Literature DB >> 33546408 |
Gianluca Testa1, Serena Maria Chiara Giardina1, Annalisa Culmone1, Andrea Vescio1, Matteo Turchetta1, Salvatore Cannavò1, Vito Pavone1.
Abstract
Knee osteoarthritis (OA) is a chronic, degenerative, and progressive disease of articular cartilage, producing discomfort and physical disability in older adults. Thirteen percent of elderly people complain of knee OA. Management options for knee OA could be divided into the following categories: conservative, pharmacological, procedural, and surgical. Joint replacement is the gold standard, reserved for severe grades of knee OA, due to its complications rate and increased risk of joint revision. A nonsurgical approach is the first choice in the adult population with cartilage damage and knee OA. Yearly, more than 10% of knee OA-affected patients undergo intra-articular injections of different drugs, especially within three months after OA diagnosis. Several molecules, such as corticosteroids injection, hyaluronic acid (HA), and platelet-rich plasma (PRP), are managed to reduce the symptoms of patients with knee OA. The aim of this review was to offer an overview of intra-articular injections used for the treatment of OA and report the conventional pharmacological products used.Entities:
Keywords: corticosteroids; hyaluronic acid; injection therapy; intra-articular injections; knee osteoarthritis; platelet-rich plasma
Year: 2021 PMID: 33546408 DOI: 10.3390/jfmk6010015
Source DB: PubMed Journal: J Funct Morphol Kinesiol ISSN: 2411-5142